Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 25:1287:342072.
doi: 10.1016/j.aca.2023.342072. Epub 2023 Nov 29.

Development of an integrated sample amplification control for salivary point-of-care pathogen testing

Navaporn Sritong  1 , Winston Wei Ngo  1 , Karin F K Ejendal  1 , Jacqueline C Linnes  2
Affiliations

Development of an integrated sample amplification control for salivary point-of-care pathogen testing

Navaporn Sritong et al. Anal Chim Acta. .

Abstract

Background: The COVID-19 pandemic has led to a rise in point-of-care (POC) and home-based tests, but concerns over usability, accuracy, and effectiveness have arisen. The incorporation of internal amplification controls (IACs), essential control for translational POC diagnostics, could mitigate false-negative and false-positive results due to sample matrix interference or inhibition. Although emerging POC nucleic acid amplification tests (NAATs) for detecting SARS-CoV-2 show impressive analytical sensitivity in the lab, the assessment of clinical accuracy with IACs is often overlooked. In some cases, the IACs were run spatially, complicating assay workflow. Therefore, the multiplex assay for pathogen and IAC is needed.

Results: We developed a one-pot duplex reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay for saliva samples, a non-invasive and simple collected specimen for POC NAATs. The ORF1ab gene of SARS-CoV-2 was used as a target and a human 18S ribosomal RNA in human saliva was employed as an IAC to ensure clinical reliability of the RT-LAMP assay. The optimized assay could detect SARS-CoV-2 viral particles down to 100 copies/μL of saliva within 30 min without RNA extraction. The duplex RT-LAMP for SARS-CoV-2 and IAC is successfully amplified in the same reaction without cross-reactivity. The valid results were easily visualized in triple-line lateral flow immunoassay, in which two lines (flow control and IAC lines) represent valid negative results and three lines (flow control, IAC, and test line) represent valid positive results. This duplex assay demonstrated a clinical sensitivity of 95%, specificity of 100%, and accuracy of 96% in 30 clinical saliva samples.

Significance: IACs play a crucial role in ensuring user confidence with respect to the accuracy and reliability of at-home and POC molecular diagnostics. We demonstrated the multiplex capability of SARS-COV-2 and human18S ribosomal RNA RT-LAMP without complicating assay design. This generic platform can be extended in a similar manner to include human18S ribosomal RNA IACs into different clinical sample matrices.

Keywords: Diagnostic; Internal amplification control; Lateral flow immunoassay; Reverse transcription loop-mediated isothermal amplification; SARS-CoV-2; Saliva.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Jacqueline C. Linnes is co-founder of EverTrue LLC, a diagnostics company developing paper-based POC NAATs, and co-founder of OmniVis Inc. NAAT company developing POC diagnostics. Navaporn Sritong, Winston Wei Ngo, and Karin F. K. Ejendal have declared that they have no competing interests.

Update of

Similar articles

See all similar articles

References

    1. Tolan NV, Horowitz GL, Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2, Clin. Lab. Med 42 (2022) 223–236. 10.1016/j.cll.2022.03.002. - DOI - PMC - PubMed
    1. Shaw JLV, Practical challenges related to point of care testing, Pract. Lab. Med 4 (2016) 22–29. 10.1016/j.plabm.2015.12.002. - DOI - PMC - PubMed
    1. Figueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, Prat I, Hatzold K, Urassa W, Baggaley R, Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis, Lancet HIV. 5 (2018) e277–e290. 10.1016/S2352-3018(18)30044-4. - DOI - PMC - PubMed
    1. Class II Special Controls Guideline: In Vitro Diagnostic Devices for Bacillus spp. Detection, (n.d.).
    1. Shah KG, Kumar S, Yager P, Near-digital amplification in paper improves sensitivity and speed in biplexed reactions, Sci. Rep 12 (2022) 14618. 10.1038/s41598-022-18937-8. - DOI - PMC - PubMed

LinkOut - more resources